- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01256047
Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy
Effects of Preoperative Immunonutrition on Infectious Complication and Th1/Th2 Differentiation in Patients Undergoing Hepatectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators reported that preoperative immunonutrition improve the incidence of postoperative infectious complication in patients after hepatectomy, and modulation of Th1/Th2 differentiation may play important roles in this effect.
Object of this study is to investigate the effects of preoperative immunonutrition on incidence of postoperative infectious complication, and Th1/Th2 balance after hepatectomy.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Chiba, Japan, 260-8677
- Chiba University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- hepatectomy
Exclusion Criteria:
- age younger than 18 years
- ongoing infection
- gastrointestinal obstruction
- respiratory dysfunction
- cardiac dysfunction
- hepatic dysfunction
- renal failure
- history of recent immunosuppressive or immunological disease
- preoperative evidence of widespread metastatic disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: group A
preoperative immunonutrition
|
oral supplement for 5 days(1L/day) before surgery of a formula enriched with arginine, omega-3 fatty acids, and RNA
Other Names:
|
No Intervention: group B
ordinary diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
postoperative infectious complication
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
plasma IL-6, CRP, Th1/Th2 balance
Time Frame: 14 days
|
14 days
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- furukawa2009-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bile Duct Cancer
-
Mayo ClinicNational Comprehensive Cancer NetworkCompletedStage III Gallbladder Cancer AJCC v8 | Stage IIIA Gallbladder Cancer AJCC v8 | Stage IIIB Gallbladder Cancer AJCC v8 | Refractory Gallbladder Carcinoma | Stage IV Gallbladder Cancer AJCC v8 | Stage IV Distal Bile Duct Cancer AJCC v8 | Stage IV Intrahepatic Bile Duct Cancer AJCC v8 | Stage IVB Gallbladder... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Extrahepatic Bile Duct Cancer | Unresectable Extrahepatic Bile Duct Cancer | Liver and Intrahepatic Biliary Tract CancerUnited States
-
National Cancer Institute (NCI)RecruitingBile Duct Cancer | Biliary Cancer | Cancer of the Bile DuctUnited States
-
UNICANCERCompletedLiver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct CancerFrance
-
Innovative Digestive Health Education and Research...NinePoint MedicalUnknownCholangiocarcinoma | Bile Duct Cancer | Primary Sclerosing Cholangitis | Bile Duct Diseases | Pancreatic Ductal Adenocarcinoma | Pancreas Cancer | Bile Duct Neoplasms | Biliary Stricture | Bile Duct Obstruction | Bile Duct Obstruction, Extrahepatic | Pancreatic Duct Stricture | Bile Duct Lesions | Bile Duct Neoplasms... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedMalignant Neoplasm | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Adenocarcinoma of the Gallbladder | Adenocarcinoma of the Extrahepatic Bile DuctUnited States
-
Instituto Ecuatoriano de Enfermedades DigestivasUniversity of Sao Paulo; Universitair Ziekenhuis Brussel; The Methodist Hospital... and other collaboratorsCompletedCommon Bile Duct Neoplasms | Non-Neoplastic Bile Duct DisorderUnited States, Ecuador, Belgium, Brazil
-
Gangnam Severance HospitalKorea Institute of Science and TechnologyCompletedBile Duct Obstruction, ExtrahepaticKorea, Republic of
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Cholangiocarcinoma of the Extrahepatic Bile Duct | Cholangiocarcinoma of the GallbladderUnited States, Canada
-
Institut Paoli-CalmettesCompletedNonresectable Bile Duct CancerFrance
Clinical Trials on Oral IMPACT
-
Centre Hospitalier Universitaire de NiceNovartisCompleted
-
Istituto Oncologico Veneto IRCCSRecruitingColorectal AdenocarcinomaItaly
-
University Hospital, LilleSantelys Association; Groupement Interrégional de Recherche Clinique et d'InnovationRecruitingPancreatic Cancer | SarcopeniaFrance
-
Raincy Montfermeil Hospital GroupNot yet recruiting
-
Prince of Songkla UniversityCompleted
-
Chiba UniversityCompletedPancreatic Cancer | Bile Duct CancerJapan
-
Chiba UniversityUnknownPancreatic Tumor | Bile Duct TumorJapan
-
Assistance Publique - Hôpitaux de ParisNestlé FoundationCompletedHepatectomy | Elective Hepatectomy | Malignant TumorsFrance
-
Chiba UniversityCompletedPancreaticoduodenectomyJapan
-
University of CopenhagenUnknownPneumonia | Malnutrition | Pulmonary Disease | Muscle Loss | Lung InfectionDenmark